Beschreibung
InhaltsangabeDedication: A Tribute to Dr. Lionel Opie. Preface. Acknowledgments. I: Ischemia/Reperfusion Injury: Basic Mechanisms. 1. PTCA Acutely Expands Perfused Myocardial Mass and Increases Flow Homogeneity; G. Sambuceti, et al. 2. Angiogenic Therapy by Coronary Collateral Recruitment and Arteriogenesis; M. Fujita. 3. Regulatory Role of ERK-Dependent Pathways in Activity of the Na+/H+ Exchanger in the Healthy and Ischemic Myocardium; L. Fliegel, et al. 4. Sodium Overload and Mitochondrial Damage in Inschemic/Reperfused Heart; S. Takeo, et al. 5. Antisense-Induced Underexpression of Manganese Superoxide Dismutase Extends Myocardial Ischemia-Reperfusion Injury; S. Hoshida, et al. 6. Phospholamban Phosphorylation During Ischemia and Reperfusion Injury: Mechanisms and Functional Implications; A. Mattiazzi, et al. 7. Phospholipase C-Mediated Signaling in Ischemic Heart Disease; P.S. Tappia, et al. 8. Effects of Sequential Ischemia-Reperfusion Cycles on Cyclic Nucleotide Phosphodiesterase Activity in Pig Heart; T. Podzuweit, et al. 9. Inducible Nitric Oxide Synthase in Cardiac Adaption to Ischemia; J. Slezak, et al. 10. Long Term Follow-Up of Leukocyte Function During Myocardial Reperfusion Injury; E. Röth, et al. 11. Mechanisms of Cellular Alterations Due to Ischemia-Reperfusion Injury in the Heart; R. Temsah, et al. 12. Mechanisms for Ischemia/Reperfusion Injury: Application of 23Na Magnetic Resonance Spectroscopy; K. Imahashi, H. Kusuoka. II: Mechanisms Underlying Ischemic Preconditioning-InducedCardioprotection. 13. Is Reduced Cell Swelling a Plausible End-Effector of Ischemic Preconditioning Protection? C.E. Ganote, et al. 14. Cardioprotection by Mitochondrial KATP Channel in Both Early and Late Preconditioning; Yigang Wang, et al. 15. Role of Mitochondrial Membrane Potential in Cardiac Protection Against Ischemia; Meifeng Xu, et al. 16. Hypoxic Reperfusion After Brief Ischemia Potentiates Ischemic Preconditioning in Isolated Rat Hearts; M.-C. Toufektsian, et al. 17. Molecular Basis for the Cardioprotective Effect of Herbal Drugs in Ischemic Heart Disease: An Experimental Study; S.K. Gupta, et al. 18. Ischaemic and Pharmacological Preconditioning is Associated with Attenuation of p38 MAPK Activation During Sustained Ischaemia and Reperfusion; A. Lochner, et al. 19. A Role for the Phosphatidylinositol-3-Kinase Pathway in Preconditioning; E. Murphy, et al. 20. Myofilament Calcium Responsiveness in Stunning and Preconditioning; N.G. Pérez. 21. How to Mediate Cardioprotection in Ischemic Hearts &endash; Role of Adenosine; M. Kitakaze. 22. On the Role of Adenosine in Classical and Interorgan Preconditioning of the Heart; D.A. Liem, et al. 23. Adenosine A3 Receptor Induced Delayed Preconditioning: Essential Role of Nuclear Factor κB, Nitric Oxide Synthase and Mitochondrial KATP Channels; T.C. Zhao, R.C. Kukreja. 24. Activation of Adenosine A1 and A3 Receptors Protects Mitochondria During Hypoxia in Cardiomyocytes by Distinct Mechanisms; V. Shneyvays, et al. 25. Non Ischemic Myocardial Preconditioning b
